Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance.
CYP3A4 is a dominant human liver cytochrome P450 enzyme engaged in the metabolism and disposition of >50% of clinically relevant drugs and held responsible for many adverse drug-drug interactions. CYP3A4 and its mammalian liver CYP3A orthologs are endoplasmic reticulum (ER)-anchored monotopic proteins that undergo ubiquitin (Ub)-dependent proteasomal degradation (UPD) in an ER-associated degradation (ERAD) process. These integral ER proteins are ubiquitinated in vivo, and in vitro studies have identified the ER-integral gp78 and the cytosolic co-chaperone, CHIP (C terminus of Hsp70-interacting protein), as the relevant E3 Ub-ligases, along with their cognate E2 Ub-conjugating enzymes UBC7 and UbcH5a, respectively. Using lentiviral shRNA templates targeted against each of these Ub-ligases, we now document that both E3s are indeed physiologically involved in CYP3A ERAD/UPD in cultured rat hepatocytes. Accordingly, specific RNAi resulted in ≈80% knockdown of each hepatic Ub-ligase, with a corresponding ≈2.5-fold CYP3A stabilization. Surprisingly, however, such stabilization resulted in increased levels of functionally active CYP3A, thereby challenging the previous notion that E3 recognition and subsequent ERAD of CYP3A proteins required ab initio their structural and/or functional inactivation. Furthermore, coexpression in HepG2 cells of both CYP3A4 and gp78, but not its functionally inactive RING-finger mutant, resulted in enhanced CYP3A4 loss greater than that in corresponding cells expressing only CYP3A4. Stabilization of a functionally active CYP3A after RNAi knockdown of either of the E3s, coupled with the increased CYP3A4 loss on gp78 or CHIP coexpression, suggests that ERAD-associated E3 Ub-ligases can influence clinically relevant drug metabolism by effectively regulating the physiological CYP3A content and consequently its function.
Kim
Sung-Mi
SM
Department of Cellular & Molecular Pharmacology, Bioengineering & Therapeutic Sciences and the Liver Center, University of California, San Francisco, California 94158-2517, USA.
Acharya
Poulomi
P
Engel
Juan C
JC
Correia
Maria Almira
MA
D000818:Animals; D002478:Cells, Cultured; D051544:Cytochrome P-450 CYP3A / Q000235:genetics / Q000378:metabolism*; D004721:Endoplasmic Reticulum / Q000378:metabolism; D004795:Enzyme Stability; D057809:HEK293 Cells; D056945:Hep G2 Cells; D022781:Hepatocytes / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D006801:Humans; D015151:Immunoblotting; D008099:Liver / Q000166:cytology / Q000201:enzymology; D008297:Male; D008856:Microscopy, Fluorescence; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D034622:RNA Interference; D051381:Rats; D017207:Rats, Sprague-Dawley; D060285:Receptors, Autocrine Motility Factor; D018121:Receptors, Cytokine / Q000235:genetics / Q000378:metabolism*; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000378:metabolism*; D054875:Ubiquitination
D018121:Receptors, Cytokine; D051544:Cytochrome P-450 CYP3A; C555000:AMFR protein, human; D060285:Receptors, Autocrine Motility Factor; C540442:Stub1 protein, rat; D044767:Ubiquitin-Protein Ligases; D046988:Proteasome Endopeptidase Complex
Biochemistry. 2001 Sep 25;40(38):11318-26
11560479
J Pharmacol Exp Ther. 2005 Jul;314(1):128-38
15769864
Biochemistry. 1998 Dec 15;37(50):17448-57
9860860
J Cell Biol. 2002 Jul 8;158(1):91-101
12105183
PLoS One. 2009;4(2):e4531
19225562
Biochemistry. 2009 Sep 8;48(35):8483-90
19642705
Expert Rev Anticancer Ther. 2008 Feb;8(2):207-17
18279062
Hum Mol Genet. 2010 May 1;19(9):1741-55
20147319
J Biol Chem. 2010 Mar 19;285(12):8830-9
20089858
Biochemistry. 2007 Jul 3;46(26):7793-803
17550236
J Biol Chem. 2003 Dec 5;278(49):49332-41
14507928
Nature. 2006 Mar 23;440(7083):551-5
16554822
J Biol Chem. 1997 Apr 11;272(15):9771-8
9092510
Mol Cell. 2005 Sep 16;19(6):829-40
16168377
Annu Rev Pharmacol Toxicol. 2005;45:439-64
15822184
Nat Cell Biol. 2001 Jan;3(1):100-5
11146634
J Biol Chem. 2004 Dec 17;279(51):52970-7
15466472
Exp Biol Med (Maywood). 2010 Mar;235(3):278-89
20404045
J Biol Chem. 2001 May 11;276(19):16193-200
11278356
Arch Biochem Biophys. 1992 Sep;297(2):228-38
1497342
Drug Metab Dispos. 1999 Aug;27(8):909-15
10421618
Nat Cell Biol. 2001 Jan;3(1):93-6
11146632
Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2836-42
15665051
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11589-94
16868077
J Biol Chem. 2001 Nov 16;276(46):42938-44
11557750
Science. 2006 Oct 13;314(5797):268-74
16959974
J Biol Chem. 2007 Sep 14;282(37):26865-26873
17650504
Cell. 2006 Aug 11;126(3):571-82
16901789
Nat Cell Biol. 2001 Jan;3(1):24-9
11146622
J Biol Chem. 2006 Feb 24;281(8):4646-53
16373356
Genes Dev. 2001 Oct 15;15(20):2660-74
11641273
Mol Cell Biol. 2008 Jun;28(12):4018-25
18411298
Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):341-6
16407162
Nat Cell Biol. 2007 Apr;9(4):379-90
17369820
Chem Rev. 2009 Apr;109(4):1561-74
19243134
Biochem J. 2005 Jun 1;388(Pt 2):647-55
15673284
Biochemistry. 2005 Dec 13;44(49):16333-40
16331994
Nat Med. 2007 Dec;13(12):1504-9
18037895
Mol Pharmacol. 2002 May;61(5):1146-53
11961133
Semin Cell Dev Biol. 2007 Dec;18(6):780-91
17942349
J Biol Chem. 2004 Oct 29;279(44):45676-84
15331598
Nat Rev Mol Cell Biol. 2008 Dec;9(12):944-57
19002207
Drug Metab Dispos. 2004 Jul;32(7):699-706
15205384
J Biol Chem. 2009 Feb 27;284(9):5671-84
19095658
J Biol Chem. 2004 Sep 10;279(37):38184-93
15247208
Arch Biochem Biophys. 2009 Mar 1;483(1):66-74
19103148
Biochem J. 1999 Jun 1;340 ( Pt 2):453-8
10333489
Mol Pharmacol. 2006 Jun;69(6):1897-904
16556771
Cell Mol Life Sci. 2004 Jul;61(13):1546-61
15224180
Biochem Biophys Res Commun. 2009 Dec 18;390(3):758-62
19835843
Arch Biochem Biophys. 1999 Oct 15;370(2):258-70
10510285
J Biol Chem. 2004 Jan 30;279(5):3525-34
14593114
Drug Metab Rev. 2003 May-Aug;35(2-3):107-43
12959413
EMBO J. 2003 Oct 15;22(20):5446-58
14532117
Arch Biochem Biophys. 2001 Sep 1;393(1):106-16
11516167
Mol Biol Cell. 2008 Apr;19(4):1328-36
18216283
Nature. 2007 Mar 15;446(7133):333-7
17310145
Biochemistry. 1997 Dec 2;36(48):14741-50
9398194
Mol Cell Biol. 1999 Jun;19(6):4535-45
10330192
Mol Cell. 2009 Jun 26;34(6):674-85
19560420
Mol Pharmacol. 2005 May;67(5):1460-9
15703377
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14422-7
11724934
Semin Cell Dev Biol. 2007 Dec;18(6):770-9
17950636
Arch Biochem Biophys. 1987 Nov 1;258(2):436-51
3674884
Cell Stress Chaperones. 2003 Winter;8(4):303-8
15115282
Expert Opin Drug Metab Toxicol. 2007 Feb;3(1):33-49
17269893
Mol Pharmacol. 2009 Sep;76(3):503-15
19520899
Toxicol Appl Pharmacol. 2004 Sep 15;199(3):316-31
15364547
J Biol Chem. 1984 Jun 10;259(11):6812-7
6725272
EMBO Rep. 2001 Dec;2(12):1133-8
11743028
Arch Biochem Biophys. 1999 May 1;365(1):45-53
10222037
Mol Pharmacol. 2010 Apr;77(4):575-92
20071449
Mol Biol Cell. 1998 Jan;9(1):209-22
9437001
Arch Biochem Biophys. 1999 May 1;365(1):31-44
10222036
Biochem Pharmacol. 1989 Apr 15;38(8):1313-9
2495801
Cell. 2008 Jan 11;132(1):101-12
18191224